Desferoxamine (DFO)—Mediated iron chelation: Rationale for a novel approach to therapy for brain cancer

Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage

Brodeur, G. M., Seeger, R. C., Schwab, M., VARMUS, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,261 · see citing works

Reduction of Ribonucleotides

Thelander, L., & Reichard, P. A. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001025 · Cited by 1,160 · see citing works

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 706 · see citing works

The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism

Keberle, H. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb54077.x · Cited by 615 · see citing works

Iron-induced carcinogenesis: The role of redox regulation

Toyokuni, S. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02111-6 · Cited by 562 · see citing works

Iron regulates nitric oxide synthase activity by controlling nuclear transcription.

Weiss, G., Werner-Felmayer, G., Werner, E. R., Grünewald, K., Wachter, H., & Hentze, M. W. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.969 · Cited by 412 · see citing works

Results of Long-Term Iron-Chelating Therapy

Gabutti, V., & Piga, A. G. (2009) · Acta Haematologica · doi:10.1159/000203853 · Cited by 379 · see citing works

The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents

Richardson, D. R., Tran, E., & Ponka, P. (1995) · Blood · doi:10.1182/blood.v86.11.4295.bloodjournal86114295 · Cited by 346 · see citing works

Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells.

Dorfman, D. M., Wilson, D. B., Bruns, G. A. P., & Orkin, S. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48426-8 · Cited by 278 · see citing works

Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels.

White, K., & Munro, H. N. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68398-x · Cited by 208 · see citing works

The Potential of Iron Chelators of the Pyridoxal Isonicotinoyl Hydrazone Class as Effective Antiproliferative Agents II: The Mechanism of Action of Ligands Derived From Salicylaldehyde Benzoyl Hydrazone and 2-Hydroxy-1-Naphthylaldehyde Benzoyl Hydrazone

Richardson, D. R., & Milnes, K. (1997) · Blood · doi:10.1182/blood.v89.8.3025 · Cited by 206 · see citing works

Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators.

Nyholm, S. H., Mann, G. J., Johansson, A. G., Bergeron, R. J., Gräslund, A., & Thelander, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74300-2 · Cited by 199 · see citing works

Effects of a single course of deferoxamine in neuroblastoma patients.

Donfrancesco, A., Deb, G., Dominici, C., Pileggi, D., Castello, M. A., & Helson, L. (1990) · PubMed · Cited by 196 · see citing works

In vitro and in vivo effects of deferoxamine in neonatal acute leukemia

Estrov, Z., Tawa, A., Wang, X., Dube, I., Sulh, H., Cohen, A., Gelfand, E. W., & Freedman, M. H. (1987) · Blood · doi:10.1182/blood.v69.3.757.757 · Cited by 187 · see citing works

Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy

Porter, J. B., Abeysinghe, R. D., Marshall, L., Hider, R. C., & Singh, S. (1996) · Blood · doi:10.1182/blood.v88.2.705.bloodjournal882705 · Cited by 185 · see citing works

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects

Summers, M. R., Jacobs, A., Tudway, D. C., Perera, P., & Ricketts, C. (1979) · British Journal of Haematology · doi:10.1111/j.1365-2141.1979.tb01167.x · Cited by 179 · see citing works

The uptake of iron and transferrin by the human malignant melanoma cell

Richardson, D. R., & Baker, E. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90018-9 · Cited by 179 · see citing works

Effects of Positive Iron Status at a Cellular Level

McCord, J. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1996.tb03876.x · Cited by 150 · see citing works

Antineuroblastoma activity of desferoxamine in human cell lines.

Blatt, J., & Stitely, S. (1987) · PubMed · Cited by 146 · see citing works

Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.

Brodie, C., Siriwardana, G., Lucas, J., Schleicher, R., Terada, N., Szepesi, Á., Gelfand, E. W., & Seligman, P. A. (1993) · PubMed · Cited by 132 · see citing works

Transcriptional Regulation by Iron of the Gene for the Transferrin Receptor

Rao, K., Harford, J. B., Rouault, T. A., McClelland, A., Ruddle, F. H., & Klausner, R. D. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.1.236 · Cited by 128 · see citing works

Hypoxia‐induced vascular endothelial growth factor expression in normal rat astrocyte cultures

Ijichi, A., Sakuma, S., & Tofilon, P. J. (1995) · Glia · doi:10.1002/glia.440140203 · Cited by 125 · see citing works

Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs

Kontoghiorghes, G. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03415-h · Cited by 112 · see citing works

New Perspectives on Iron: An Introduction

Boldt, D. H. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40625-1 · Cited by 109 · see citing works

Conservation of ferritin heavy subunit gene structure: implications for the regulation of ferritin gene expression.

Murray, M. T., White, K., & Munro, H. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7438 · Cited by 109 · see citing works

Iron in Brain Function and Dysfunction with Emphasis on Parkinson’s Disease

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (2008) · European Neurology · doi:10.1159/000116719 · Cited by 106 · see citing works

Deferoxamine inhibition of human neuroblastoma viability and proliferation.

Becton, D. L., & Bryles, P. (1988) · PubMed · Cited by 105 · see citing works

Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors

Pollock, R. E., Lotzová, E., & Stanford, S. D. (1992) · Cancer · doi:10.1002/1097-0142(19921015)70:8 · Cited by 100 · see citing works

Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis

Wright, J., Chan, A. K., Choy, B. K., et al. (1990) · Biochemistry and Cell Biology · doi:10.1139/o90-199 · Cited by 92 · see citing works

Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: The effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake

Richardson, D. R., & Baker, E. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610119 · Cited by 86 · see citing works

Differential ferrioxamine test for measuring chelatable body iron

Fielding, J. (1965) · Journal of Clinical Pathology · doi:10.1136/jcp.18.1.88 · Cited by 79 · see citing works

The sequences of human and bovine genes of the phosphate carrier from mitochondria contain evidence of alternatively spliced forms.

Dolce, V., Iacobazzi, V., Palmieri, F., & Walker, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34081-4 · Cited by 75 · see citing works

Deferoxamine in children with recurrent neuroblastoma.

Blatt, J. (1995) · PubMed · Cited by 72 · see citing works

Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: Preliminary results

Donfrancesco, A., Bernardi, B. D., Carli, M., Mancini, A., Nigro, M. A., Sio, L. D., Casale, F., Bagnulo, S., Helson, L., & Deb, G. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00068-t · Cited by 70 · see citing works

Deferoxamine, Cyclophosphamide, Etoposide, Carboplatin, and Thiotepa (D-CECaT)

Donfrancesco, A., Deb, G., Dominici, C., et al. (1992) · American Journal of Clinical Oncology · doi:10.1097/00000421-199208000-00009 · Cited by 66 · see citing works

Iron-Chelating Agents in Non-Iron Overload Conditions

Voest, E. E., Vreugdenhil, G., & Marx, J. J. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-6-199403150-00008 · Cited by 63 · see citing works

New Perspectives on Iron: An Introduction

Boldt, D. H. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199910000-00001 · Cited by 63 · see citing works

Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures

Sinor, A. D., Irvin, S. M., Cobbs, C., et al. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00976-7 · Cited by 62 · see citing works

Brain iron: location and function.

Beard, J. L., Connor, J. D., & Jones, B. C. (1993) · PubMed · Cited by 62 · see citing works

Potential of iron chelators as effective antiproliferative agents

Richardson, D. R. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-10-11-1164 · Cited by 61 · see citing works

Up-regulation of vascular endothelial growth factor production by iron chelators.

Beerepoot, L. V., Shima, D. T., Kuroki, M., Yeo, K. T., & Voest, E. E. (1996) · PubMed · Cited by 60 · see citing works

The mechanisms of iron uptake by fetal rat hepatocytes in culture

Trinder, D., Morgan, E. H., & Baker, E. (1986) · Hepatology · doi:10.1002/hep.1840060508 · Cited by 58 · see citing works

Role of Deferoxamine in Tumor Therapy

Donfrancesco, A., Deb, G., Sio, L. D., Cozza, R., & Castellano, A. (2009) · Acta Haematologica · doi:10.1159/000203951 · Cited by 58 · see citing works

Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators

Renton, F. J., & Jeitner, T. M. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00099-8 · Cited by 57 · see citing works

Antileukemic effects of deferoxamine on human myeloid leukemia cell lines.

Becton, D. L., & Roberts, B. (1989) · PubMed · Cited by 57 · see citing works

Organization and sequence of the human gene encoding cytokeratin 8

Krauss, S. J. K., & Franke, W. W. (1990) · Gene · doi:10.1016/0378-1119(90)90285-y · Cited by 56 · see citing works

Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron

Alcantara, O., Reddy, S. V., Roodman, G. D., & Boldt, D. H. (1994) · Biochemical Journal · doi:10.1042/bj2980421 · Cited by 55 · see citing works

Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-beta and PKC-alpha gene expression and role of the 5'-flanking region of the PKC-beta gene in the response to ferric transferrin

Alcantara, O., Obeid, L. M., Hannun, Y. A., Ponka, P., & Boldt, D. (1994) · Blood · doi:10.1182/blood.v84.10.3510.3510 · Cited by 54 · see citing works

The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.

Richardson, D. R., & Ponka, P. (1994) · PubMed · Cited by 54 · see citing works

Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts.

Selig, R. A., White, L. E., Gramacho, C. M., et al. (1998) · PubMed · Cited by 53 · see citing works

Potential of iron chelators as effective antiproliferative agents

Richardson, D. R. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y97-156 · Cited by 48 · see citing works

Roles of iron in neoplasia

Weinberg, E. D. (1992) · Biological Trace Element Research · doi:10.1007/bf02785242 · Cited by 45 · see citing works

Iron-Transferrin Requirements and Transferrin Receptor Expression in Proliferating Cells

Kühn, L. C., Schulman, H. M., & Ponka, P. (2024) · CRC Press eBooks · doi:10.1201/9781003574811-14 · Cited by 43 · see citing works

Effects of agents that inhibit cellular iron incorporation on bladder cancer cell proliferation

Seligman, P. A., Schleicher, R. B., Siriwardana, G., Domenico, J. M., & Gelfand, E. W. (1993) · Blood · doi:10.1182/blood.v82.5.1608.1608 · Cited by 41 · see citing works

Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by iron-transferrin but not by soluble iron

Alcantara, O., Javors, M. A., & Boldt, D. (1991) · Blood · doi:10.1182/blood.v77.6.1290.1290 · Cited by 36 · see citing works

Screening of Transcriptionally Regulated Genes Following Iron Chelation in Human Astrocytoma Cells

Ye, Z., & Connor, J. R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1554 · Cited by 28 · see citing works

The long 3′‐untranslated regions of the PDGF‐A and ‐B mRNAs are only distantly related

Hoppe, J., Schumacher, L., Eichner, W., et al. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80297-1 · Cited by 22 · see citing works

Cloning and characterization of the human tartrate-resistant acid phosphatase (TRAP) gene.

Fleckenstein, E., Dirks, W. G., Dehmel, U., et al. (1996) · PubMed · Cited by 21 · see citing works

Deferoxamine-induced cytotoxicity in human neuronal cell lines: protection by free radical scavengers

Lee, Y. S., & Wurster, R. D. (1995) · Toxicology Letters · doi:10.1016/0378-4274(94)03235-y · Cited by 15 · see citing works

Effect of Different Exposures to Desferrioxamine on Neuroblastoma Cell Lines

Valle, P., Timeus, F. S., Piglione, M., et al. (1995) · Pediatric Hematology and Oncology · doi:10.3109/08880019509009473 · Cited by 15 · see citing works

D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age.

Donfrancesco, A., Deb, G., Dominici, C., et al. (1996) · PubMed · Cited by 10 · see citing works

The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer

Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.2 · Cited by 721 · see citing works

Stabilization of HIF-1α is critical to improve wound healing in diabetic mice

Botusan, I. R., Sunkari, V. G., Savu, O., Catrina, A. I., Grünler, J., Lindberg, S., Pereira, T., Ylä-Herttuala, S., Poellinger, L., Brismar, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805230105 · Cited by 533 · see citing works

Oxidative Stress and Iron Homeostasis: Mechanistic and Health Aspects

Galaris, D., & Pantopoulos, K. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701713104 · Cited by 352 · see citing works

Iron as a central player and promising target in cancer progression

Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · see citing works

Ferritinophagy drives uropathogenic<i>Escherichia coli</i>persistence in bladder epithelial cells

Bauckman, K. A., & Mysorekar, I. U. (2016) · Autophagy · doi:10.1080/15548627.2016.1160176 · Cited by 100 · see citing works

Iron accumulation and neurotoxicity in cortical cultures treated with holotransferrin

Chen‐Roetling, J., Liu, W., & Regan, R. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.021 · Cited by 13 · see citing works

Acquisition, storage and release of iron by cultured human hepatoma cells

Hirsh, M., Konijn, A. M., & Iancu, T. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00221-5 · Cited by 25 · see citing works

Inhibition of growth of the lymphocyte lines by deferoxamine under various iron-supply conditions.

Kovár, J., Seligman, P., & Ew, G. (1991) · PubMed · Cited by 2 · see citing works

Cancer, General Principles of Biological Treatments

Huñis, A. P. (2022) · doi:10.37191/mapsci-jcrtp-1(1)-003

The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.

Richardson, D. R., & Ponka, P. (1994) · PubMed · Cited by 54 · see citing works